Department of Molecular Pharmacology, Physiology and Biotechnology, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
Cytoskeleton (Hoboken). 2013 Jul;70(7):349-59. doi: 10.1002/cm.21114. Epub 2013 Jul 3.
Gastric cancer, a disease of disparity associated with Helicobacter pylori (H. pylori) infection, is the world's second leading cause of cancer deaths. The pathogen H. pylori target the epithelial adhesion receptors, E-cadherin, and β1-integrin, to modulate the host cytoskeleton via disruption of the epithelial cell polarity necessary for maintaining the infection, but how this leads to the development of the carcinoma is widely unclear. While Rho family GTPases' signaling to the cytoskeleton and these receptors is required for initiating and maintaining the infection, the responsible effectors, and how they might influence the etiology of the carcinomas are currently unknown. Here we discuss the potential role of the Cdc42-IQGAP1 axis, a negative regulator of the tumor suppressors E-cadherin and β1-integrin, as a potential driver of H. pylori-induced gastric carcinoma and propose avenues for addressing its disparity. Chronic dysfunction of the IQGAP1-signaling pathway, resulting from H. pylori-induced disruption of cell polarity, can explain the pathogenesis of the carcinoma, at least, in subsets of infected population, and thus could provide a potential means for personalized medicine.
胃癌是一种与幽门螺杆菌(H. pylori)感染相关的具有差异性的疾病,是全球第二大癌症死亡原因。病原体 H. pylori 靶向上皮黏附受体 E-钙黏蛋白和β1-整合素,通过破坏维持感染所必需的上皮细胞极性来调节宿主细胞骨架,但这如何导致癌症的发展还广泛不清楚。虽然 Rho 家族 GTPases 向细胞骨架和这些受体的信号传导对于启动和维持感染是必需的,但负责的效应子以及它们如何影响癌症的病因目前尚不清楚。在这里,我们讨论了 Cdc42-IQGAP1 轴作为 H. pylori 诱导的胃癌潜在驱动因素的可能作用,该轴是肿瘤抑制因子 E-钙黏蛋白和β1-整合素的负调节剂,并提出了解决其差异性的途径。幽门螺杆菌诱导的细胞极性破坏导致的 IQGAP1 信号通路的慢性功能障碍,可以解释癌症的发病机制,至少在部分感染人群中是这样,因此可能为个性化医疗提供一种潜在手段。